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Bird's-eye pattern ﬁbrosisSummary IgG4-related kidney disease (IgG4-RKD) occasionally progresses to chronic renal failure and is
pathologically characterized by IgG4-positive lymphoplasmacyte-rich tubulointerstitial nephritis with stori-
form ﬁbrosis (bird's-eye pattern ﬁbrosis). Although radiology reveals a heterogeneous distribution of affect-
ed areas in this disease, their true distribution within the whole kidney is still unknown because of difﬁculty
in estimating this from needle biopsy samples. Using 5 autopsy specimens, the present study histologically
characterized the distribution and components of interstitial inﬂammation and ﬁbrosis in IgG4-RKD. Inter-
stitial lymphoplasmacytic inﬁltration or ﬁbrosis was observed in a variety of anatomical locations such as
intracapsular, subcapsular, cortical, perivascular, and perineural regions heterogeneously in a patchy distri-
bution. They tended to be more markedly accumulated around medium- and small-sized vessels. Storiform
ﬁbrosis was limited to the cortex. Immunostaining revealed nonﬁbrillar collagens (collagen IV and VI) and
ﬁbronectin predominance in the cortical lesion, including storiform ﬁbrosis. In contrast, ﬁbril-forming col-
lagens (collagen I and III), collagenVI, and ﬁbronectin were the main components in the perivascular lesion.
In addition, α-smooth muscle actin–positive myoﬁbroblasts were prominently accumulated in the early le-
sion and decreased with progression, suggesting that myoﬁbroblasts produce extracellular matrices forming
a peculiar ﬁbrosis. In conclusion, perivascular inﬂammation or ﬁbrosis of medium- and small-sized vessels☆ Competing interests: The authors have no conﬂicts of interest related to this study.
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165Autopsy analysis of IgG4-related kidney diseaseis a newly identiﬁed pathologic feature of IgG4-RKD. Because storiform ﬁbrosis contains mainly nonﬁbril-
lar collagens, “interstitial ﬁbrosclerosis” would be a suitable term to reﬂect this. The relation between the
location and components of ﬁbrosis determined in whole kidney samples provides new clues to the patho-
physiology underlying IgG4-RKD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
IgG4-related kidney disease (IgG4-RKD) is a major mani-
festation of IgG4-related disease (IgG4-RD) [1,2]. The typical
histology, IgG4-positive plasma cell (PC)–rich tubulointersti-
tial nephritis (TIN), occasionally progresses to chronic renal
failure [3,4].
One basic pathologic feature of IgG4-RKD is a curious dis-
tribution of its inﬂammation. Radiologically, the lesions dis-
tribute heterogeneously within the kidney such as capsule,
cortex, medulla, and renal pelvis [1]. Reﬂecting the radiologic
ﬁndings, histology shows its speciﬁc features: a clear demar-
cation between lesions and nonlesions, and extension of a le-
sion often beyond the renal capsule [3,5]. However, it
remains unknown how IgG4-positive PCs inﬁltrate heteroge-
neously in the kidney structures because of the insufﬁcient size
of tissue specimens obtainable by needle biopsy. In this regard,
autopsy specimens are ideal for analyzing the distribution of
inﬂammation and ﬁbrosis.
In addition to location, the interstitial ﬁbrosis, called stori-
form ﬁbrosis or bird's-eye pattern ﬁbrosis, is another impor-
tant disease-speciﬁc histologic hallmark of IgG4-RKD that
clearly distinguishes IgG4-related from non–IgG4-related
TIN [3,5]. Electron microscopic analysis suggests that
storiform ﬁbrosis contains more extracellular matrix (ECM)
components than ﬁbrous materials [3]. Thus, this peculiar ﬁ-
brosis may consist of different ECM proteins from other stages
of ﬁbrosis in IgG4-RKD and non–IgG4-related TIN. Howev-
er, it remains undeterminedwhether different stages of intersti-
tial lesions, including storiform ﬁbrosis, contain the same
ECM proteins.
In the present study, we histologically identiﬁed the charac-
teristic distribution of interstitial inﬂammation and ﬁbrosis in
IgG4-RKD, using autopsy kidneys. Subsequently, we ana-
lyzed and compared the characteristic components of intersti-
tial ﬁbrosis according to the locations by immunostaining.
Our ﬁndings may facilitate better understanding of the patho-
physiology of IgG4-RKD.2. Materials and methods
2.1. Subjects
Five autopsy-derived whole kidneys from IgG4-RKD pa-
tients were enrolled (Kanazawa University, Nagaoka RedCross Hospital, Nagaoka Chuo General Hospital, Toranomon
Hospital, and Okayama University). The diagnoses of IgG4-
RKD and IgG4-RD were made according to established diag-
nostic criteria [2,4,6]. Serum samples were also obtained at the
time of diagnosis of IgG4-RD. Cases 3 and 4were described in
previous reports [7,8]. Biopsied kidney specimens from idio-
pathic TIN (n = 3), diabetic nephropathy (n = 2), and benign
nephrosclerosis (n = 2) were used to compare ECM proteins
with those of IgG4-related TIN. The study was approved by
the ethics committee of Kanazawa University (no. 2013-833).2.2. Histochemical and immunohistochemical
analyses
Autopsies were performed 2.2, 1.5, 8, 1.5, and 8 hours after
death in cases 1 to 5, respectively. All samples were ﬁxed in
formaldehyde and embedded in parafﬁn blocks and were used
for hematoxylin and eosin, periodic acid–Schiff, periodic acid
methenamine silver (PAM), Masson's trichrome (MT) stain-
ing, and immunostaining. Speciﬁc primary antibodies for im-
munostaining were as follows: monoclonal mouse anti-
human IgG4 antibody (clone HP6025, ready to use; Nichirei
Bioscience, Tokyo, Japan), monoclonal mouse anti-human
CD138 antibody (clone B-A38, 1:100; AbD Serotec, Oxford,
UK), monoclonal mouse anti-human collagen I antibody
(clone COL-1, 1:100; Abcam, Cambridge, UK), polyclonal
rabbit anti-human collagen III antibody (1:400; Abcam), poly-
clonal rabbit anti-human collagen IV antibody (1:200;
Abcam), monoclonal mouse anti-human collagen V antibody
(clone 1E2-E4/Col5, 1:50; Abcam), polyclonal rabbit anti-
human collagen VI antibody (1:100; Abcam), polyclonal rab-
bit anti-human ﬁbronectin antibody (1:2000; Dako, Glostrup,
Denmark), and monoclonal mouse anti-human α-smooth mus-
cle actin (α-SMA) antibody (clone 1A4, 1:400; Sigma-
Aldrich, St. Louis, MO). For immunostaining, antigen was
retrieved by a microwave (10 mmol/L citrate buffer; pH 6.0)
for IgG4, CD138, collagen I, ﬁbronectin, and α-SMA or
100 μg/mL of proteinase K (Wako Pure Chemical Industries,
Osaka, Japan) for collagen III, IV, V, and VI. Thereafter,
primary antibodies of rabbit origin were incubated in EnVision
labeled polymer–horseradish peroxidase (Dako), and primary
antibodies of mouse origin were incubated in a Histoﬁne kit
(Nichirei Bioscience) followed by reaction with peroxidase-
conjugated streptavidin (Nichirei Bioscience). Peroxidase
activity was visualized using a liquid diaminobenzidine
substrate (Dako). Hematoxylin was used to stain nuclei.
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stage and location. Stages were deﬁned as follows: stage A,
acute interstitial nephritis pattern with minimal interstitial ﬁ-
brosis; stage B, active cellular inﬁltration withmild but distinct
expansile interstitial ﬁbrosis; stage C, interstitial ﬁbrosis dom-
inant with mild cellular inﬁltration; and stage D, advanced in-
terstitial ﬁbrosis with less cellular inﬁltration [3,4]. Storiform
ﬁbrosis or bird's-eye pattern ﬁbrosis is deﬁned as an irregular
pattern of ﬁbrosis resembling the spokes of a cartwheel with
inﬁltrating cells radiating from the center [3,9]. Locations were
divided into intracapsule, subcapsule, cortex (except for sub-
capsular, perivascular, and perineural lesions), perivascula-
ture, perinerve, and medulla.
For comparison of different staining at the same location,
we obtained synchronized images using Nano-Zoomer 2.1S
(Hamamatsu Photonics, Hamamatsu, Japan).
2.3. Statistics
All data are presented as absolute numbers or means ± SEs.
Statistical differences between 2 or more than 3 groups were
evaluated using unpaired Student t test and Welch's test, respec-
tively. P b .05 was deemed to indicate statistical signiﬁcance.3. Results
3.1. Clinical proﬁles
The patients were all Japanesemales with an average age of
71.2 ± 2.2 (range, 64-76) years at the time of diagnosis of
IgG4-RD (Table 1). The mean intervals from diagnosis to
death were 63.2 ± 15.5 (range, 1-108) months. All patients
demonstrated serum IgG and IgG4 elevations (IgG mean,
3886 mg/dL; range, 2430-4813 mg/dL; IgG4 mean, 1284
mg/dL; range, 319-1750 mg/dL). Of the 5 cases, 4 (80%)
had hypocomplementemia, and all had extrarenal involve-
ment, including pancreas, salivary gland, lung, liver, bile duct,
aorta, retroperitoneum, lymph nodes, prostate gland, and skin.
Two patients (40%; cases 1 and 2) were receiving predniso-
lone at the time of death. The other 2 patients (cases 4 and 5)
were receiving chemotherapy for malignancy. The causes of
death were sepsis in 2 cases and sudden death of unknown
cause, nonocclusive mesenteric ischemia, and recurrence of a
mucinous cystadenocarcinoma of the appendix with peritoneal
dissemination in one each of the remaining 3 cases.
3.2. Histopathologic features
Microscopically, all cases showed dense interstitial lympho-
plasmacytic inﬁltration and/or ﬁbrosis (Table 2). In 2 of 5 spec-
imens without corticosteroid (cases 3 and 5), storiform ﬁbrosis
was present (Fig. 1A). Obliterative phlebitis or lymphoid
follicles were absent in all cases. Lymphoplasmacyte inﬁltrationor ﬁbrosis was detected around interlobar, arcuate, or interlobu-
lar artery segments (width 200-500 μm) or veins in all cases
(Table 2 and Fig. 1C-F). Two patients who had received
long-term corticosteroid therapy (cases 1 and 2) showed mild
and patchy inﬁltration of lymphoplasmacytes and mild phlebitis
but had a large ﬁbrotic area lacking tubules with few remnant
glomeruli and arteries (Fig. 1G and H).
With respect to location, interstitial inﬂammation was not-
ed in the intracapsule in 2, subcapsule in 3, cortex and perivas-
culature in 5, perinerve in 1, but in the medulla in none
(Table 3). Lymphoplasmacytic inﬁltration or ﬁbrosis was lo-
cated mainly in the cortex and perivasculature. Of note is
that each specimen contained a variety of stages of inﬂamma-
tion in different locations and that storiform ﬁbrosis was limit-
ed to the cortex.
By immunohistochemistry, a marked inﬁltration of IgG4-
positive cells was demonstrated in the tubulointerstitium
(mean IgG4 counts, 63.4; range, 3.4-116/high-power ﬁeld
[HPF]; Table 2 and Fig. 1B), and the IgG4/CD138 ratio was
increased (mean IgG4/CD138 ratio, 68.2%; range, 14%-
110%). From these data, 4 of 5 patients (cases 1 and 3-5) sat-
isﬁed diagnostic criteria for IgG4-RD and IgG4-RKD and the
consensus statement on the pathology of IgG4-RD [2,4,6,9].
The remaining one who had received long-term corticosteroid
(case 2) showed little lymphoplasmacytic inﬁltration at autop-
sy (IgG4-positive cell count, 3.4/HPF; IgG4/CD138 ratio,
14%), but numerous IgG4-positive PCs inﬁltrated the tubu-
lointerstitium in the kidney biopsy specimen.
3.3. Location- and stage-dependent components of
interstitial ﬁbrosis
According to the location and stage, we investigated char-
acteristics of IgG4-RKD using standard staining and immuno-
histochemistry (Figs. 2, 3 and Table 4).
Intracapsular lesions showed stages A and D without stori-
form ﬁbrosis. At stage D, PAM-positive and MT-blue appar-
ent ﬁbers were predominant and were stained by collagen I
and ﬁbronectin. Subcapsular lesions showed stages B and D
without storiform ﬁbrosis. In these lesions, ﬁbrosis was
PAM negative and was stained by ﬁbronectin. Cortical lesions
revealed all stages including storiform ﬁbrosis. Thin ﬁbers
were apparent at stage B and subsequently formed thick ﬁbers
and encircled inﬁltrating lymphoplasmacytes at stage C (stori-
form ﬁbrosis), and ﬁnally, a ﬁber-rich lesion formed stage D.
The ﬁbers were PAM positive and MT blue and were stained
by collagen IV, VI, and ﬁbronectin predominantly, but less
with collagen I and III. Perivascular lesions showed stages
A, B, and D, but no storiform ﬁbrosis. Thin ﬁbers similar to
those in the cortical lesions appeared at stage B. At stage D, bi-
phasic ﬁbers were predominant components showing PAM-
negative MT–weak blue and PAM-positive MT–strong blue
pictures. The former ﬁbers consisted of collagen VI and ﬁbro-
nectin, and collagen I and III were added to the latter. Perineu-
ral lesions showed only stage B. PAM-positive and MT-blue
Table 1 Clinical and serological features of 5 autopsy cases
Case
no.
Sex Age at the
time of
diagnosis of
IgG4-RD (y)
Period
between
diagnosis of
IgG4-RD
and death
(mo)
IgG
(mg/dL)
IgG4
(mg/dL)
C3
(mg/dL)
C4
(mg/dL)
CH50
(IU/mL)
Extrarenal
lesions
Malignancy CS
therapy
Other
therapy
Last dose
of PSL
(mg/dL)
1 Male 67 108 4803 319 56 15 NA Sa, Ao/
RPF,
Lu, Ly
− + − 5
2 Male 64 69 4001 1340 55 2 10 Pa − + − 5
3 Male 76 1 4813 1750 50 2 b15 Sa, Ao/
RPF, Ec,
Lu, Li, Bi,
Me, Pr,
Sk, Ly
− − − 0
4 Male 76 67 3381 1520 59 5 28 Pa, Sa,
Lu, Ly
Lung cancer − Chemo 0
5 Male 73 71 2430 1490 90 18 45 Pa, Sa, Pr Mucinous cyst,
adenocarcinoma
of the appendix
+ (past) Chemo 0
Abbreviations: CS, corticosteroid; PSL, prednisolone; NA, not available; Sa, salivary gland; Ao/RPF, aorta and retroperitoneal ﬁbrosis; Lu, lung; Li, liver; Ly,
lymph node; Pa, pancreas; Ec, endocrine; Bi, bile duct; Me, mesenterium; Pr, prostate; Sk, skin; Chemo, chemotherapy.
167Autopsy analysis of IgG4-related kidney diseaseﬁbers appeared stained with collagen I and III. No specimens
contained collagen V in any locations or stages.
To compare the ECM components between IgG4-RKD and
non–IgG4-related TIN, we also performed immunostaining in
kidney needle biopsy specimens of non–IgG4-related TIN, in-
cluding idiopathic TIN, diabetic nephropathy, and benign
nephrosclerosis (Supplementary Figure). In the cortex, intersti-
tial ﬁbrosis tended to contain more collagen I than collagen III,
IV, VI, and ﬁbronectin. The components did not differ be-
tween the etiologies of non–IgG4-related TIN.
3.4. Decrease of myoﬁbroblasts with advancing stage
We investigated interstitial α-SMA–positive cell inﬁltra-
tion according to the location and stage. The number of
α-SMA–positive cells did not differ at the same stage inTable 2 Histopathologic ﬁndings of 5 autopsy cases
Case no. IgG4-positive PC
inﬁltration (/HPF)
IgG4+/CD138+ ratio (%) Sto
ﬁb
1 38.4 48 −
2 3.4 14 −
3 115.8 83 +
4 80 86 −
5 77.8 110 +any of the locations. With regard to the stage, the number of
α-SMA–positive cells was signiﬁcantly higher in stages A
and B and decreased with advancing stage (stage A, 72.4 ±
12.3; stage B, 50.3 ± 6.4; stage C, 31.4 ± 6.1; stage D;
12.6 ± 4.6/HPF; Fig. 4).4. Discussion
In the present study, analysis of autopsy specimens clariﬁed
characteristic locational features of inﬂammation and ﬁbrosis
in IgG4-RKD. Light microscopy revealed that interstitial in-
ﬂammation or ﬁbrosis was located mainly in the cortical and
perivascular area of medium- and small-sized vessels. The
perivascular distribution resembles that of IgG4-related peri-
aortitis, which shows IgG4-positive PC inﬁltration in the aorticriform
rosis
Periarterial PC
inﬁltration
Periarterial
ﬁbrosis
Perivenous lesion
+ − ++
− +++ +
+++ − +++
+++ − +++
+++ − +++
BA
DC
FE
G H
Fig. 1 Histopathologic ﬁndings of IgG4-related kidney disease in autopsy cases. A, Storiform ﬁbrosis (bird's-eye pattern ﬁbrosis). Inﬁltrating
lymphoplasmacytes are encircled by PAM-strong positive thick ﬁbers (case no. 5, PAM staining, original magniﬁcation, ×200). B, Immunostain-
ing for IgG4. Dense IgG4-positive cells inﬁltrate in the interstitium (case no. 5, original magniﬁcation, ×400). C, and D, Fiber-rich interstitial le-
sions are observed around arcuate and interlobular artery (case no. 2, PAM staining, original magniﬁcations, ×3 [C] and ×25 [D]). E and F, Fiber-
rich interstitial lesions are also observed around arcuate vein (case no. 4, PAM staining, original magniﬁcations, ×12.5 [E] and ×25 [F]). G and H,
Acellular ﬁbrous lesion with clear demarcation is observed in intracapsule and subcapsule (case no. 1,MT staining, original magniﬁcations, ×3 [G]
and ×25 [H]).
Table 3 Stage classiﬁcation of interstitial ﬁbrosis according to location
Case no. Intracapsule Subcapsule Cortex Perivasculature Perinerve Medulla
1 D D B A + B – None
2 A B + D D A + B + D – None
3 – – A + B + C B B None
4 None B None A + B + D – None
5 – – A + B + C A + B – None
Abbreviations: –, no sample was obtained; None, no lesions existed.
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Fig. 2 Immunostaining for interstitial inﬂammation and ﬁbrosis of intracapsular, subcapsular, and perineural lesions in IgG4-related kidney dis-
ease patients. Depicted stages and locations were as follows: intracapsular lesions, stage D (case no. 1); subcapsular lesions, stage D (case no. 1);
perineural lesions, stage B (case no. 3). Collagen I and ﬁbronectin were dominant in intracapsular lesions. Fibronectin was dominant in subcapsular
lesions. Collagens I and III were dominant in perineural lesions. Original magniﬁcation, ×200.
169Autopsy analysis of IgG4-related kidney disease
Cortex Cortex Perivascular Perivascular
PA
M
Co
lla
ge
n 
ty
pe
 I
Co
lla
ge
n 
ty
pe
 II
I
Co
lla
ge
n 
ty
pe
 IV
Co
lla
ge
n 
ty
pe
 V
I
Fi
br
on
ec
tin
stage A+B stage Dstage A+B stage C
Fig. 3 Immunostaining for interstitial inﬂammation and ﬁbrosis of perivascular and cortical lesions in IgG4-related kidney disease patients.
Depicted stages and locations were as follows: cortex lesions, stage A + B (case no. 5); cortex lesions, stage C (case no. 5); perivascular lesions,
stage A + B (case no. 1); perivascular lesions, stage D (case no. 4). Collagen IV, VI, and ﬁbronectin were dominant in cortical lesions, including
storiform ﬁbrosis, whereas collagen I, VI, and ﬁbronectin were dominant in perivascular lesions. Original magniﬁcation, ×200.
170 S. Hara et al.adventitia [10,11]. In addition to aortic lesions, IgG4-RD
can also affect coronary artery, forming as a periarteritis
[12,13]. These similarities of perivascular lesions suggest that
lymphoplasmacytic inﬁltration extends along the adventitia
of large-, medium-, and then small-sized arteries, forming aheterogeneous distribution in the involved organs including
kidney in IgG4-RD. Because few reports have focused on
the presence or absence of periarterial lesions in individual af-
fected organs such as pancreas, further studies are needed to
evaluate the signiﬁcance of periarterial lesions in IgG4-RD.
Table 4 Components in interstitial ﬁbrosis according to stage
and distribution
Location/
stages
Stage A Stage B Stage C Stage D
Intracapsule Negative – – Col I, FN
Subcapsule Negative FN – FN
Cortex Negative Col IV, VI,
FN
Col III, IV,
VI, FN
Col III, IV,
VI, FN
Perivascular Negative Col I, III,
IV, VI, FN
– Col I, III,
VI, FN
Perinerve Negative Col I, III – –
Medulla – – – –
Abbreviations: Col, collagen; FN, ﬁbronectin; –, no sample was obtained;
Negative, no lesions existed in sample.
171Autopsy analysis of IgG4-related kidney diseaseIn addition, further studies using animal models are needed to
conﬁrm or refute the hypothesis that perivascular inﬂamma-
tion underlies the pathophysiology of IgG4-RKD.
Another ﬁnding in our study is that mixed stages are pres-
ent in the same kidney in different locations. Histology con-
tained areas of active inﬂammation with background
interstitial ﬁbrosis, even after the achievement of remission
by corticosteroid therapy. These ﬁndings are important be-
cause clinically inactive but histologically active inﬂammation
may result in extension of interstitial ﬁbrosis and renal
dysfunction.
Storiform ﬁbrosis (bird's-eye pattern ﬁbrosis) is a charac-
teristic pathologic feature of IgG4-RKD; however, its localiza-
tion and accumulated protein are unknown. We found that it
was formed only in the cortical lesions, and the component
was predominantly nonﬁbrillar ECM proteins. Collagen, a
representative ECM protein, is classiﬁed as ﬁbril-forming,A
Stage A Stage B
Stage C Stage D
Fig. 4 α-SMA–positive cell inﬁltration according to stage. A, Represen
Original magniﬁcation, ×400. B, Comparison of α-SMA–positive cells am
increasing stage. ⁎P b .05. Stage A, n = 5; stage B, n = 12; stage C, n = 2network-forming, beaded-ﬁlament-forming, and other colla-
gens by their function and domain homologies [14]. Immuno-
staining analysis in the present study revealed that the cortical
lesions, including storiform ﬁbrosis, contained mainly
network-forming (collagen IV) and beaded-ﬁlament-forming
collagens (collagen VI), whereas the perivascular lesions con-
tained ﬁbril-forming collagens (collagen I and III). In contrast,
renal ﬁbrosis in non–IgG4-related TIN consists mainly of
ﬁbril-forming collagens (collagen I and III) in our study and
conﬁrmed previous reports [15,16]. Thus, the cortical lesions
in IgG4-RKD have different components from those of non–
IgG4-RD–derived renal ﬁbrosis. In addition, a previous
electron microscopic study showed that storiform ﬁbrosis
contained low-dense matrix components in addition to
interstitial-type collagen ﬁbrils [3], supporting our immuno-
histochemical ﬁndings. Thus, storiform ﬁbrosis would be spe-
ciﬁc in the point of nonﬁbrillar collagen predominance,
compared to interstitial ﬁbrosis of non–IgG4-related TIN,
which has ﬁbril-forming collagen predominance. We would
like to propose that the character of storiform ﬁbrosis could
be described as “ﬁbrosclerosis” or “sclerosing ﬁbrosis” to em-
phasize the ECM-rich composition in addition to ﬁbrous com-
ponents in IgG4-RKD.
Our next interest is the difference in interstitial components
between the cortical and perivascular lesions of IgG4-RKD.
We identiﬁed α-SMA–positive cells, a typical marker of myo-
ﬁbroblasts [15], among lymphoplasmacytes in the early phase,
which decreased in parallel with advancing stage. Electron mi-
croscopy also revealed myoﬁbroblasts among lymphoplasma-
cyte inﬁltrates in the early phase [3]. The number of tissue α-
SMA–positive cells and amount of collagen accumulation
are correlated with the disease activity of IgG4-RD [17]. Myo-
ﬁbroblasts produce collagen IV and ﬁbronectin in addition to
collagen I and III [18,19]. These ﬁndings suggest that0
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172 S. Hara et al.myoﬁbroblasts are a major source of ECMs in IgG4-RD. Fur-
thermore, a variety of studies using rodent models have indi-
cated that myoﬁbroblasts have multiple origins such as
resident ﬁbroblasts, bone marrow–derived ﬁbroblasts, peri-
cytes, epithelial-mesenchymal transition from tubular cells,
and endothelial-mesenchymal transition [20,21]. These differ-
ent origins of myoﬁbroblasts may associate with the produc-
tion of different ECMs according to the locations even in the
same proﬁbrotic cytokine environment including transforming
growth factor β (TGF-β), which is speculated to be the
main cytokine for organ ﬁbrogenesis in IgG4-RKD [16,22].
In the analyses of ﬁbrosis in other involved organs of
IgG4-RD, some new ﬁndings were clariﬁed. One group found
that epithelial-mesenchymal transition may associate with ﬁ-
brosis in the lacrimal gland involvement of IgG4-RD [23].
Some other groups recently showed in studies on IgG4-
related sialadenitis that M2-type macrophages and mast
cells are other contributors to organ ﬁbrogenesis [24–26];
however, it remains undetermined whether these cells and
epithelial-mesenchymal transition contribute to the ﬁbrogen-
esis of IgG4-RKD. Our data are limited to IgG4-RKD, pre-
cluding any conclusion as to whether storiform ﬁbrosis in
other organs involved by IgG4-RD contains characteristic
ECM components.
Cytokine environment would determine the type of
ECMs produced by myoﬁbroblasts, forming characteristic in-
terstitial ﬁbrosis in IgG4-RKD. The major cytokine is TGF-β,
which is secreted by regulatory T (Treg) cells [27,28]. In IgG4-
RKD, quantitative reverse transcription polymerase chain re-
action and immunostaining studies have shown that TGF-β
messenger RNA was overexpressed in the biopsy specimens
of IgG4-RKD and that Treg cells expressed TGF-β in the inter-
stitium, and the number of Treg cells was correlated with
IgG4-positive PC inﬁltration [16,22]. These ﬁndings suggest
that Treg-mediated TGF-β affects ﬁbrogenesis in IgG4-RKD.
TGF-β is not speciﬁc for IgG4-RKD because this cytokine is
also expressed in many chronic kidney diseases as a common
pathway for progression of interstitial ﬁbrosis [15]. Therefore,
our ﬁnding, namely, that storiform ﬁbrosis has characteristic
ECMs, suggests that another speciﬁc cytokine may also con-
tribute to the ﬁbrogenesis in IgG4-RKD.
In conclusion, autopsy specimens indicated that perivascu-
lar lymphoplasmacytic inﬁltration or ﬁbrosis of medium- and
small-sized vessels would characterize the distribution and
pathophysiology of IgG4-RKD. Because our ﬁndings showed
a predominant component of nonﬁbrillar collagens as stori-
form ﬁbrosis, we suggest that this lesion be referred to as ﬁbro-
sclerosis. Our ﬁndings may provide further insight into the
pathogenesis of IgG4-RKD.Supplementary data
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